An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Clinical trial NCT06952634 · COMPLETED

Trial details

NCT number: NCT06952634
Sponsor: Alumis Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2025-04-29
Primary completion: 2026-03-24
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.